Bollard Group LLC Gsk PLC Transaction History

Bollard Group LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$40.46 - $43.52 $2.22 Million - $2.38 Million	-54,759 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $30,535 - $33,092	775 Added 1.44%	54,759 $2.19 Million
Q1 2019 May 10, 2019	BUY	$38.57 - $42.69 $25,186 - $27,876	653 Added 1.22%	53,984 $2.26 Million
Q4 2018 Feb 05, 2019	BUY	$37.8 - $42.69 $6,010 - $6,787	159 Added 0.3%	53,331 $2.04 Million
Q3 2018 Nov 08, 2018	BUY	$39.75 - $42.69 $6,002 - $6,446	151 Added 0.28%	53,172 $2.14 Million
Q2 2018 Aug 09, 2018	BUY	$39.61 - $42.76 $7,803 - $8,423	197 Added 0.37%	53,021 $2.14 Million
Q1 2018 May 14, 2018	BUY	$36.18 - $40.15 $1.91 Million - $2.12 Million	52,824 New	52,824 $2.06 Million
Q4 2017 Jan 29, 2018	SELL	$35.34 - $41.9 $1.82 Million - $2.16 Million	-51,453 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$39.44 - $41.55 $2.03 Million - $2.14 Million	51,453	51,453 $2.09 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.5B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

Stay updated on Bollard Group LLC with notifications on news.